Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Acta Oncologica (Stockholm, Sweden)|September 17, 2021
Clinical outcomes in cancer patients with COVID-19 in SwedenLisa Bondeson, Anna Thulin, Lars Ny, et al.
Obesity Research|January 27, 2004
Computerized determination of adipocyte sizeTom Björnheden, Bozena Jakubowicz, Max Levin, et al.
Acta Oncologica (Stockholm, Sweden)|June 2, 2019
Real-world data on PD-1 inhibitor therapy in metastatic melanomaAnna Arheden, Joanna Skalenius, Sara Bjursten, et al.
Case Reports in Oncology|December 12, 2019
Response to BRAF/MEK Inhibition in A598_T599insV BRAF Mutated MelanomaSara Bjursten, Christoffer Vannas, Stefan Filges, et al.
Plos One|November 28, 2012
Increased expression of the very low-density lipoprotein receptor mediates lipid accumulation in clear-cell renal cell carcinomaJeanna Perman Sundelin, Marcus Ståhlman, Annika Lundqvist, et al.
The Journal of Biological Chemistry|January 10, 2022
Analysis of normal levels of free glycosaminoglycans in urine and plasma in adultsSinisa Bratulic, Angelo Limeta, Francesca Maccari, et al.
Atherosclerosis|April 7, 2009
CD44-deficiency on hematopoietic cells limits T-cell number but does not protect against atherogenesis in LDL receptor-deficient miceSara Sjöberg, Einar E Eriksson, Asa Tivesten, et al.
BJC Reports|April 11, 2025
Immune checkpoint inhibitor therapy is associated with a decreased risk of developing melanoma brain metastasesAnna Fager, Matilda Samuelsson, Roger Olofsson Bagge, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 2, 2022
pH-Dependent Protonation of Histidine Residues Is Critical for Electrostatic Binding of Low-Density Lipoproteins to Human Coronary ArteriesLars Glise, Mikael Rutberg, Liliana Håversen, et al.
Oncoimmunology|August 8, 2025
Immune-related hepatitis and hypophysitis are associated with superior survival in melanoma patients treated with combined ipilimumab and nivolumabHifaa Al Remawi, Maria Lindén, Zhiyuan Zhao, et al.
Pageof 5